- JP-listed companies
- AFC-HD AMS Life Science Co.,Ltd.
- Balance sheet
AFC-HD AMS Life Science Co.,Ltd.【JP:2927】Balance sheet
Market cap
¥12.7B
P/E ratio
8.5x
| 2013/08 | 2014/08 | 2015/08 | 2016/08 | 2017/08 | 2018/08 | 2019/08 | 2020/08 | 2021/08 | 2022/08 | 2023/08 | 2024/08 | 2025/08 | |
| Cash and cash equivalents | - | 4,119 | 4,039 | 3,723 | 3,392 | 4,080 | 4,437 | 4,726 | 9,222 | 10,378 | 11,182 | 12,173 | 11,303 |
| Total cash & short-term investments | - | 4,119 | 4,039 | 3,723 | 3,392 | 4,080 | 4,437 | 4,726 | 9,222 | 10,378 | 11,182 | 12,173 | 11,303 |
| Accounts receivable, net | - | 1,690 | 2,090 | 1,896 | 2,054 | 2,058 | 2,164 | 2,190 | 2,245 | 2,579 | - | - | - |
| Inventories | - | 871 | 928 | 872 | 990 | 1,067 | 1,088 | 1,043 | 1,638 | 1,530 | 1,695 | 1,931 | 1,845 |
| Total current assets | - | 8,117 | 8,964 | 8,232 | 8,309 | 9,207 | 9,630 | 10,009 | 15,852 | 17,125 | 19,875 | 21,935 | 22,325 |
| Property, plant and equipment, net | - | 8,008 | 7,807 | 7,609 | 7,966 | 8,064 | 7,856 | 7,659 | 16,012 | 15,923 | 17,145 | 19,601 | 21,336 |
| Marketable securities, non-current | - | 522 | 329 | 297 | 306 | 624 | 560 | 596 | 736 | 849 | 540 | 589 | 568 |
| Total non-current assets | - | 8,695 | 8,302 | 8,112 | 8,453 | 8,853 | 8,698 | 8,540 | 19,900 | 20,223 | 21,177 | 25,074 | 26,402 |
| Total assets | - | 16,812 | 17,266 | 16,344 | 16,762 | 18,060 | 18,327 | 18,549 | 35,752 | 37,349 | 41,053 | 47,008 | 48,727 |
| Accounts payable | - | 1,645 | 2,199 | 1,822 | 1,884 | 2,005 | 1,814 | 2,009 | 2,967 | 3,414 | 3,265 | 3,587 | 3,780 |
| Short-term debt | - | 2,990 | 2,290 | 2,290 | 2,733 | 2,553 | 2,763 | 2,763 | 3,963 | 6,817 | 7,915 | 9,018 | 9,473 |
| Long-term debt, current | - | 806 | 689 | 638 | 1,749 | 321 | 831 | 103 | 1,027 | 182 | 303 | 520 | 8,965 |
| Total current liabilities | - | 6,633 | 6,812 | 6,001 | 7,749 | 6,241 | 6,896 | 6,204 | 11,802 | 13,219 | 14,854 | 17,403 | 26,001 |
| Long-term debt, non-current | - | 1,992 | 2,257 | 1,777 | 445 | 1,317 | 486 | 1,082 | 9,691 | 10,136 | 11,320 | 13,293 | 5,475 |
| Total non-current liabilities | - | 3,609 | 3,366 | 2,970 | 1,349 | 2,166 | 1,321 | 1,881 | 11,289 | 11,685 | 13,060 | 15,628 | 7,526 |
| Total liabilities | - | 10,242 | 10,178 | 8,971 | 9,098 | 8,407 | 8,217 | 8,085 | 23,091 | 24,904 | 27,914 | 33,031 | 33,527 |
| Common stock and paid-in capital | - | 2,888 | 2,879 | 2,875 | 2,875 | 4,328 | 4,328 | 4,328 | 4,570 | 4,772 | 4,771 | 4,783 | 4,786 |
| Retained earnings | - | 3,778 | 4,264 | 4,573 | 4,857 | 5,412 | 5,914 | 6,239 | 7,421 | 7,903 | 8,570 | 9,433 | 10,428 |
| Stockholders' equity | 6,324 | 6,570 | 7,089 | 7,373 | 7,664 | 9,653 | 10,110 | 10,463 | 12,660 | 12,445 | 13,138 | 13,977 | 15,200 |
| Total debt | - | 5,789 | 5,237 | 4,705 | 4,927 | 4,190 | 4,079 | 3,948 | 14,681 | 17,135 | 19,538 | 22,831 | 23,913 |
| Net debt | - | 1,669 | 1,198 | 982 | 1,535 | 111 | -358 | -777 | 5,459 | 6,757 | 8,356 | 10,658 | 12,609 |
| D/E ratio (%) | - | 88.1 | 73.9 | 63.8 | 64.3 | 43.4 | 40.3 | 37.7 | 116 | 137.7 | 148.7 | 163.3 | 157.3 |
| Working capital | - | - | - | - |